1 |
XIE S, WU Z, QI Y, et al.. The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges[J/OL]. Biomed. Pharmacother., 2021, 138: 111450[2021-03-06]. .
|
2 |
WU F, WANG L, ZHOU C. Lung cancer in China: current and prospect[J]. Curr. Opin. Oncol., 2021, 33(1): 40-46.
|
3 |
AZEVEDO A S, FOLLAIN G, PATTHABHIRAMAN S, et al.. Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?[J]. Cell Adhes. Migr., 2015, 9(5): 345-356.
|
4 |
李芳芳,穆登彩,杨春艳,等.KIF26B在非小细胞肺癌发生发展过程中的表达与功能研究[J].生物技术进展,2020,10(3):273-283.
|
5 |
王姣姣,耿圆圆,张家耀,等.肝细胞癌循环肿瘤细胞标志物及检测方法研究进展[J].生物技术进展,2015,5(2):113-119.
|
6 |
PIÑEIRO R, MARTÍNEZ-PENA I, LÓPEZ-LÓPEZ R. Relevance of CTC clusters in breast cancer metastasis[J]. Adv. Exp. Med. Biol., 2020, 1220: 93-115.
|
7 |
WEI C, YANG C, WANG S, et al.. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis[J/OL]. Mol. Cancer, 2019, 18(1): 64[2019-03-30]. .
|
8 |
CASTRO-GINER F, ACETO N. Tracking cancer progression: from circulating tumor cells to metastasis[J/OL]. Genome Med., 2020, 12(1): 31[2020-03-19]. .
|
9 |
ZHONG X, ZHANG H, ZHU Y, et al.. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy[J/OL]. Mol. Cancer, 2020, 19(1): 15[2020-01-24]. .
|
10 |
VASANTHARAJAN S S, ECCLES M R, RODGER E J, et al.. The epigenetic landscape of circulating tumour cells[J/OL]. Biochim. Biophys. Acta Rev. Cancer, 2021, 1875(2): 188514[2021-01-23]. .
|
11 |
STOECKLEIN N H, FISCHER J C, NIEDERACHER D, et al.. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution[J]. Expert Rev. Mol. Diagn., 2016, 16(2): 147-164.
|
12 |
THORÉN F, JOHNSSON Å A, HELLSTRÖM M, et al.. Extracolonic findings-identification at low-dose CTC[J]. Radiat. Prot. Dosim., 2021, 195(3-4): 188-197.
|
13 |
NAGRATH S, SEQUIST L V, MAHESWARAN S, et al.. Isolation of rare circulating tumour cells in cancer patients by microchip technology[J]. Nature, 2007, 450(7173): 1235-1239.
|
14 |
LABIB M, KELLEY S O. Circulating tumor cell profiling for precision oncology[J]. Mol. Oncol., 2021, 15(6): 1622-1646.
|
15 |
LIN D, SHEN L, LUO M, et al.. Circulating tumor cells: biology and clinical significance[J/OL]. Signal Transduct. Target. Ther., 2021, 6(1): 404[2021-11-22]. .
|
16 |
GAO Y, FAN W H, SONG Z, et al.. Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study[J/OL]. Peer J., 2021, 9: e10777[2021-03-02]. .
|
17 |
WANG T, GAO Y, WANG X, et al.. Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics[J]. Chin. J. Cancer Res., 2022, 34(2): 95-108.
|
18 |
WATANABE M, KENMOTSU H, KO R, et al.. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter[J]. Cancer Sci., 2018, 109(8): 2539-2548.
|
19 |
RADOVICH M, JIANG G, HANCOCK B A, et al.. Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer: preplanned secondary analysis of the BRE12-158 randomized clinical trial[J]. JAMA Oncol., 2020, 6(9): 1410-1415.
|
20 |
WEI B, JIN X, WANG Q, et al.. Synthesis of carbon coated iron nitride nanoparticles by using microwave plasma technique[J/OL]. Mater. Res. Express, 2020, 7(9): 096103[2020-09-23]. .
|
21 |
高先娟,汲霞,王清路,等.羧基化石墨烯/半胱胺修饰金电极对多巴胺的电化学行为研究[J].生物技术进展,2020,10(3):292-298.
|
22 |
LIANG T, LI J, LIU X, et al.. Preparation of CD3 antibody-conjugated, graphene oxide coated iron nitride magnetic beads and its preliminary application in T cell separation[J/OL]. Magnetochemistry, 2021, 7(5): 58[2021-04-29]. .
|
23 |
LI J, WANG M, JIA R, et al.. Graphene-coated iron nitride streptavidin magnetic beads: preparation and application in SARS-CoV-2 enrichment[J/OL]. Magnetochemistry, 2022, 8(4): 41[2022-04-07]. .
|
24 |
WEISSENSTEIN U, SCHUMANN A, REIF M, et al.. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies[J/OL]. BMC Cancer, 2012, 12: 206[2012-05-30]. .
|
25 |
TALASAZ A H, POWELL A A, HUBER D E, et al.. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device[J]. Proc. Natl. Acad. Sci. USA, 2009, 106(10): 3970-3975.
|
26 |
BAKHSHI M S, RIZWAN M, KHAN G J, et al.. Design of a novel integrated microfluidic chip for continuous separation of circulating tumor cells from peripheral blood cells[J/OL]. Sci. Rep., 2022, 12(1): 17016[2022-10-11]. .
|
27 |
KARABACAK N M, SPUHLER P S, FACHIN F, et al.. Microfluidic, marker-free isolation of circulating tumor cells from blood samples[J]. Nat. Protoc., 2014, 9(3): 694-710.
|
28 |
CUI H, LI R, DU J, et al.. Rapid and efficient isolation and detection of circulating tumor cells based on ZnS:Mn2+ quantum dots and magnetic nanocomposites[J]. Talanta, 2019, 202: 230-236.
|
29 |
LEMMA S, PERRONE A M, IACO P D, et al.. Current methodologies to detect circulating tumor cells: a focus on ovarian cancer[J]. Am. J. Cancer Res., 2021, 11(9): 4111-4126.
|
30 |
XIE N, HU Z, TIAN C, et al.. In vivo detection of CTC and CTC plakoglobin status helps predict prognosis in patients with metastatic breast cancer[J]. Pathol. Oncol. Res., 2020, 26(4): 2435-2442.
|
31 |
ZHANG X, LU X, GAO W, et al.. A label-free microfluidic chip for the highly selective isolation of single and cluster CTCs from breast cancer patients[J/OL]. Transl. Oncol., 2021, 14(1): 100959[2021-01-14]. .
|